甲状腺状态与血液透析患者生活质量及心理健康的关系
该前瞻性队列纳入17家透析中心的450例血液透析患者,每6个月进行促甲状腺激素检测、SF-36问卷和Beck抑郁量表评估。分析发现较高的基线及时间依赖性促甲状腺激素水平与SF-36中精力/疲劳、躯体功能和疼痛等维度评分下降相关,但与抑郁症状评分无显著关联。
要点
- 血透患者较高促甲状腺激素水平与精力/疲劳、躯体功能及疼痛等生活质量维度受损相关。
- 促甲状腺激素水平与Beck抑郁量表评分无显著关联。
- 尚需研究明确调节甲状腺功能的治疗能否改善血透患者生活质量。
核心结论
- 在血液透析患者中,较高的血清促甲状腺激素水平与健康相关生活质量在精力/疲劳、躯体功能和疼痛等维度的受损相关。
- 基线及时间依赖性促甲状腺激素水平均与Beck抑郁量表-II评分无显著关联。
研究设计与样本
- 前瞻性队列研究,纳入2013年5月至2015年5月来自17个门诊透析设施的450例血液透析患者。
- 每6个月进行方案化促甲状腺激素检测、Short-Form 36问卷和Beck抑郁量表-II问卷调查。
- 采用扩展病例组合加实验室校正的线性混合效应模型分析基线及时间依赖性促甲状腺激素(三分位分类和连续变量)与8个SF-36维度及Beck抑郁量表-II评分的关联。
主要发现
- 分类分析中,最高基线促甲状腺激素三分位与精力/疲劳维度评分低5分相关(P=0.04)。
- 分类分析中,最高时间依赖性三分位与躯体功能评分低5分相关(P=0.03;参照:最低三分位)。
- 连续分析中,基线促甲状腺激素每升高1 mIU/L与因身体健康导致的角色限制(β=-1.3;P=0.04)、精力/疲劳(β=-0.8;P=0.03)和疼痛评分(β=-1.4;P=0.002)降低相关,相当于促甲状腺激素每升高1个标准差分别降低5分、3分和5分。
- 时间依赖性促甲状腺激素升高与因身体健康导致的角色限制评分降低相关(β=-1.0;P=0.03),相当于促甲状腺激素每升高1个标准差降低3分。
- 基线和时间依赖性促甲状腺激素均与Beck抑郁量表-II评分无显著关联。
临床怎么用
- 对血液透析患者,较高促甲状腺激素水平提示可能存在的精力/疲劳、躯体功能和疼痛等生活质量受损,需关注甲状腺状态对患者报告结局的影响。
- 目前证据不支持促甲状腺激素水平与抑郁症状的直接关联,抑郁评估仍需独立进行。
- 调节甲状腺治疗能否改善生活质量尚不明确,临床决策需个体化并等待干预研究结果。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In the general population, there is increasing recognition of the effect of thyroid function on patient-centered outcomes, including health-related quality of life and depression. Although hypothyroidism is highly prevalent in hemodialysis patients, it is unknown whether thyroid status is a risk factor for impaired health-related quality of life or mental health in this population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We examined the association of thyroid status, defined by serum thyrotropin, with health-related quality of life and depressive symptoms over time in a prospective cohort of 450 patients on hemodialysis from 17 outpatient dialysis facilities from May of 2013 to May of 2015 who underwent protocolized thyrotropin testing, Short-Form 36 surveys, and Beck Depression Inventory-II questionnaires every 6 months. We examined the association of baseline and time-dependent thyrotropin categorized as tertiles and continuous variables with eight Short-Form 36 domains and Beck Depression Inventory-II scores using expanded case mix plus laboratory adjusted linear mixed effects models. RESULTS: In categorical analyses, the highest baseline thyrotropin tertile was associated with a five-point lower Short-Form 36 domain score for energy/fatigue (P=0.04); the highest time-dependent tertile was associated with a five-point lower physical function score (P=0.03; reference: lowest tertile). In continuous analyses, higher baseline serum thyrotropin levels (+Δ1 mIU/L) were associated with lower role limitations due to physical health (β=-1.3; P=0.04), energy/fatigue (β=-0.8; P=0.03), and pain scores (β=-1.4; P=0.002), equivalent to five-, three-, and five-point lower scores, respectively, for every 1-SD higher thyrotropin. Higher time-dependent thyrotropin levels were associated with lower role limitations due to physical health scores (β=-1.0; P=0.03), equivalent to a three-point decline for every 1-SD higher thyrotropin. Baseline and time-dependent thyrotropin were not associated with Beck Depression Inventory-II scores. CONCLUSIONS: In patients on hemodialysis, higher serum thyrotropin levels are associated with impaired health-related quality of life across energy/fatigue, physical function, and pain domains. Studies are needed to determine if thyroid-modulating therapy improves the health-related quality of life of hemodialysis patients with thyroid dysfunction.
引用
- Rhee CM, Chen Y, You AS, et al. Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017. PMID: 28705886. doi:10.2215/CJN.13211216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。